A nurse in an acute care facility is reviewing medication administration protocol with another nurse. Which of the following information should the nurse include in the review?
Use one client identifier before administering medication
Read medication labels twice before administration.
Document the administration of medications after all assigned clients have been medicated.
Check the clients' allergy bands with each medication administration.
The Correct Answer is D
The correct answer is D. Checking the clients' allergy bands with each medication administration is a safety measure to prevent adverse drug reactions. According to the Healthline website, "Always ask patient about allergies, types of reactions, and severity of reactions" before giving any medication.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
The correct answer is D. Checking the clients' allergy bands with each medication administration is a safety measure to prevent adverse drug reactions. According to the Healthline website, "Always ask patient about allergies, types of reactions, and severity of reactions" before giving any medication.
Correct Answer is B
Explanation
Explanation B.Triiodothyronine
Levothyroxine is a synthetic form of the thyroid hormone thyroxine (T4). It is converted to triiodothyronine (T3), the active form of the thyroid hormone, in the body. Monitoring the levels of triiodothyronine (T3) can help assess the effectiveness of levothyroxine therapy and ensure that the client's thyroid hormone levels are within the desired therapeutic range.
Serum potassium levels in (option A) should not be monitored because they are not directly affected by levothyroxine. However, imbalances in electrolytes can occur in some individuals with thyroid disorders. Electrolyte levels may be monitored, but it is not the primary focus of monitoring for levothyroxine therapy.
Blood urea nitrogen (BUN) in (option C) should not be monitored because it is a test used to assess kidney function and is not directly related to monitoring levothyroxine therapy.
Prothrombin time (PT) in (option D) should not be monitored because it is a test used to evaluate the clotting function of the blood and is not specifically related to monitoring levothyroxine therapy.

Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.